Enliven Therapeutics director Mika K. Derynck sells USD 9.56 million in common shares - ELVN News | RalliesEnliven Therapeutics director Mika K. Derynck sells USD 9.56 million in common shares
E
ELVN• Director sells shares after option exercises
- Enliven Therapeutics director Mika K. Derynck sold 158,795 shares on Aug. 4 at a weighted average price of $60.21.
- The sale followed option exercises for the same 158,795 shares at prices ranging from $2.48 to $25.28.
- Derynck’s reported direct common stock holdings fell to zero following the transactions.
•
